Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
ACHILLION PHARMACEUTICALS IN
ACHN·00448Q201·UN·Common Stock
ACHN (ACHILLION PHARMACEUTICALS IN) is held by 0 institutional investors as of Q1 2020.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold ACHN.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $16,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $374,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $454,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $294,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $58,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $401,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $10,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $526,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $169,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $114,938 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $778,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.5M | 0.0% | — | 0 |
Showing 1-20 of 71
1 / 4
ACHNACHILLION PHARMACEUTICALS INContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer